A COMPARISON OF THE FIRST GENERATION ISTENT (G1) AND THE SECOND GENERATION ISTENT INJECT (G2). TO REPORT ON EARLY COMPLICATIONS AND EASE OF INSERTION INTO THE TRABECULAR MESHWORK

被引：0

作者：

Ioannidis, Alex ^{[1
]}

Dimopoulos, George ^{[1
]}

机构：

[1] Vis Eye Inst, Melbourne, Vic, Australia

来源：

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2016年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：100 / 100

页数：1

共 9 条

[1] Second-generation Trabecular Meshwork Bypass Stent (iStent inject) Increases Outflow Facility in Cultured Human Anterior Segments
Bahler, Cindy K.
Hann, Cheryl R.
Fjield, Todd
Haffner, David
Heitzmann, Hal
Fautsch, Michael P.
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (06) : 1206 - 1213
[2] Comparison of a second-generation trabecular bypass (iStent inject) to ab interno trabeculectomy (Trabectome) by exact matching
Al Yousef, Yousef
Strzalkowska, Alicja
Hillenkamp, Jost
Rosentreter, Andre
Loewen, Nils A.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (12) : 2775 - 2780
[3] Comparison of a second-generation trabecular bypass (iStent inject) to ab interno trabeculectomy (Trabectome) by exact matching
Yousef Al Yousef
Alicja Strzalkowska
Jost Hillenkamp
André Rosentreter
Nils A. Loewen
Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 2775 - 2780
[4] iStent Inject (Second-generation Trabecular Microbypass) Versus Nonpenetrating Deep Sclerectomy in Association With Phacoemulsification for the Surgical Treatment of Open-angle Glaucoma and Cataracts: 1-Year Results
Guedes, Ricardo A. Paletta
Gravina, Daniela M.
Guedes, Vanessa M. Paletta
Chaoubah, Alfredo
JOURNAL OF GLAUCOMA, 2020, 29 (10) : 905 - 911
[5] Synthesis of Calix[4]arene Appended Lactosylated G1 and Galactosylated G2 Generation Glycodendrimers Using a ‘CuAAC’ Click Approach
Kumar, S.
Yadav, M.S.
Singh, S.K.
Rajkhowa, S.
Tiwari, V.K.
Synthesis, 2023, 17 (A149-A166)
[6] Real-world (RW) treatment patterns and outcomes for second-line (2L) therapy and beyond in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC receiving a first-line (1L) first- or second-generation (1G/2G) EGFR tyrosine kinase inhibitor (TKI)
Shah, R.
Girard, N.
Nagar, S. P.
Griesinger, F.
Roeper, J.
Davis, K.
Bakker, N.
Thakrar, B.
Taylor, A.
Feliciano, J.
ANNALS OF ONCOLOGY, 2019, 30
[7] Comparison of phenotypic and heterotic effects affecting milk yield, composition and udder morphometry of Hair and F1, F2 and G1 generation cross-breeds of Alpine × Hair and Saanen × Hair dairy goats in a semi-intensive system
Hakan Erduran
Birol Dag
Tropical Animal Health and Production, 2022, 54
[8] Comparison of phenotypic and heterotic effects affecting milk yield, composition and udder morphometry of Hair and F1, F2 and G1 generation cross-breeds of Alpine x Hair and Saanen x Hair dairy goats in a semi-intensive system
Erduran, Hakan
Dag, Birol
TROPICAL ANIMAL HEALTH AND PRODUCTION, 2022, 54 (01)
[9] Clinical Outcomes and Adverse Events Among Patients with Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL) Initiating First-Line (1L) Ibrutinib: Analysis of Subgroups Receiving Subsequent Second Generation (2G) Bruton Tyrosine Kinase Inhibitors, Non-Bruton Tyrosine Kinase Inhibitor Therapy, or Ibrutinib Retreatment in the US Community Oncology Setting
Burke, John M.
Zackon, Ira
Wayne, Brittani
Wang, Yunfei
Murphy, John
Prescott, Jennifer
Gandra, Shravanthi
Leng, Siyang
De Nigris, Enrico
BLOOD, 2024, 144 : 7811 - 7812

← 1 →